Dulaglutide
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Company n/r · Phase 4 · Completed · Enrollment 23
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cyanocobalamin, then Dulaglutide | Obesity or overweight | n/r | 6 | n/r | n/r |
| Dulaglutide, then Cyanocobalamin | Obesity or overweight | n/r | 6 | n/r | n/r |